Skip to main content
RISE logo
Breakfast seminar Pharma Office 2022-10-07

The benefits of AI in drug development – watch the seminar

12 October 2022, 13:14

During the digital breakfast seminar on the 7th of October, Matilda Bäckberg, project manager for the Pharma Office, Erik Ylipää, researcher in AI, and Ian Cotgreave, professor of toxicology and strategist in drug development, presented the benefits and possibilities of AI in drug development.

Traditionally, many years of research are required to evaluate a new drug. A major challenge during the development process is often to efficiently and with high quality convert large amounts of data into new insights that take the project to the next stage, and this is where AI comes into the picture!

 

- It was nice to see that there was so much interest in the seminar and the subject, says Matilda Bäckberg. Erik Ylpää is a very innovative AI researcher who I'd love to work with on our pharmaceutical initiatives, especially to create tools that make it simpler for small and medium-sized businesses to determine the best course of action in their development processes. The processes for discovering, developing, producing, testing, and analyzing future medications can be significantly accelerated thanks to AI technology.

Matilda Bäckberg
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

* Mandatory By submitting the form, RISE will process your personal data.